Recruitment And Diversity

41. Patients Get More Mileage With Free Flights To Far-Flung Clinical Trial Sites 9/20/2024

    LifeLine Pilot Executive Director Lindsey Kerr shares the impact free medical flights can have on patients participating in clinical trials far from home.

42. Why Is The Reality Of Patient Engagement Not Living Up To Its Theory? 9/17/2024

    Patient Co-Next's Pauline Frank discusses why pharma knows patient engagement is important but rarely succeeds in implementing it fully.

43. If Sponsors Invite Patients To See The Final Draft Protocol, It's Already Too Late 9/17/2024

    Consultant Kamila Novak dives into the importance of early patient input — and why sponsors have a hard time getting it (and implementing it).

44. Why Are We Still Excluding Persons With Disabilities (PWDs) In Clinical Trials? 9/13/2024

    Canary Advisors Cofounder and COO Richie Kahn details the National Council on Disability's call for the inclusion of people with disabilities in clinical trials.

45. Dedicated Trialist, Nurse Navigators Help Advance Cancer Therapy Into Accelerated Approval 9/11/2024

    Thoracic medical oncologist Sally Lau, MD Lau discusses her role as a principal investigator, from the benefits of the FDA’s accelerated approval pathway to best practices for retaining a challenging patient population.

46. Pelage Embraces Diverse Patient Recruitment For Non-Hormonal Hair Loss Therapy 9/5/2024

    Pelage Pharmaceuticals’ CMO Qing Yu Christina Weng, MD discusses how the company expanded criteria to include patients of all skin and hair types and incorporate decentralized elements in their trial design for a novel hair loss treatment.

47. More Diverse Enrollment Means More Attention To I/E Language 9/4/2024

    Clinical research nurse Teri Crumb, MSN, RN, CCRC picks out a few potentially problematic inclusion/exclusion (I/E) criteria and details ways to address them.

48. 3 Surefire Ways To Design Trials That Patients Want And Need 9/3/2024

     

    Alpha Tau Medical CMO Robert Den, MD details three ways sponsors can more effectively design clinical trials with patients in mind.

     

49. A Vision For Inclusion: Designing Trials That Benefit Visually Impaired Patients 8/30/2024

    Ocugen CMO Huma Qamar, MD, MPH, CMI contends that whether targeting vision-related conditions or other medical needs, sponsors must design trials that ensure vision-impaired patients are included.

50. These 3 Areas Need Risk Management Attention Now 8/29/2024

    Consultant Jessica Cordes and medical affairs expert Oscar Segurado team up to discuss the three key areas of risk in clinical trials.